Health Discovery Corp (HDVY)

[David West]

Mon Oct 19, 2009 9:15am EDT

A New FDA-Approved Ovarian Cancer Test based on an HDC Patented Technology

HDC`s patented technology played a pivotal role in identifying biomarkers in a
recently FDA-approved ovarian cancer test developed by Vermillion, Inc.
(VRMLQ.PK).

HDC prosecuted a patent infringement action against Vermillion`s predecessor
company, Ciphergen Biosystems, Inc., which resulted in a $600,000 cash
settlement in favor of HDC and a grant of a limited license to Vermillion by
HDC. The HDC limited license grant to Vermillion is for non-exclusive use solely
for Vermillion`s SELDI-based mass spectrometer technology.

http://www.reuters.com/article/pressRelease/idUS109263+19-Oct-2009+BW20091019